P2X7 receptor

An emerging target in central nervous system diseases

B. Sperlágh, Peter Illes

Research output: Contribution to journalArticle

168 Citations (Scopus)

Abstract

The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.

Original languageEnglish
Pages (from-to)537-547
Number of pages11
JournalTrends in Pharmacological Sciences
Volume35
Issue number10
DOIs
Publication statusPublished - 2014

Fingerprint

Purinergic P2X7 Receptors
Central Nervous System Diseases
Neurology
Central Nervous System
Pathology
Inflammasomes
Explosions
Huntington Disease
Amyotrophic Lateral Sclerosis
Neuralgia
Nervous System Diseases
Mood Disorders
Pharmaceutical Preparations
Multiple Sclerosis
Parkinson Disease
Psychiatry
Epilepsy
Alzheimer Disease
Animal Models
Adenosine Triphosphate

Keywords

  • ATP
  • neurodegenerative diseases
  • P2X7 receptor
  • psychiatric disorders

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Medicine(all)

Cite this

P2X7 receptor : An emerging target in central nervous system diseases. / Sperlágh, B.; Illes, Peter.

In: Trends in Pharmacological Sciences, Vol. 35, No. 10, 2014, p. 537-547.

Research output: Contribution to journalArticle

@article{d866ac5b0c874f9a8f7d6df916866254,
title = "P2X7 receptor: An emerging target in central nervous system diseases",
abstract = "The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.",
keywords = "ATP, neurodegenerative diseases, P2X7 receptor, psychiatric disorders",
author = "B. Sperl{\'a}gh and Peter Illes",
year = "2014",
doi = "10.1016/j.tips.2014.08.002",
language = "English",
volume = "35",
pages = "537--547",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - P2X7 receptor

T2 - An emerging target in central nervous system diseases

AU - Sperlágh, B.

AU - Illes, Peter

PY - 2014

Y1 - 2014

N2 - The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.

AB - The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.

KW - ATP

KW - neurodegenerative diseases

KW - P2X7 receptor

KW - psychiatric disorders

UR - http://www.scopus.com/inward/record.url?scp=84907899903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907899903&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2014.08.002

DO - 10.1016/j.tips.2014.08.002

M3 - Article

VL - 35

SP - 537

EP - 547

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 10

ER -